22 May 2020 – BBC News
UK scientists will start testing a treatment that it hopes could counter the effects of Covid-19 in the most seriously ill patients.
It has been found those with the most severe form of the disease have extremely low numbers of an immune cell called a T-cell, these clear infection from the body.
The clinical trial will evaluate if a drug called interleukin 7, known to boost T-cell numbers, can help patients’ to recover.
The testing involves scientists from the Francis Crick Institute, King’s College London and Guy’s and St Thomas’ Hospital.